Workflow
Humana(HUM)
icon
Search documents
Humana(HUM) - 2022 Q3 - Earnings Call Transcript
2022-11-02 15:42
Humana Inc. (NYSE:HUM) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Lisa Stoner – Vice President-Investor Relations Bruce Broussard – President and Chief Executive Officer Susan Diamond – Chief Financial Officer Conference Call Participants Stephen Baxter – Wells Fargo Kevin Fischbeck – Bank of America Justin Lake – Wolfe Research Nathan Rich – Goldman Sachs Gary Taylor – Cowen Scott Fidel – Stephens George Hill – Deutsche Bank Josh Raskin – Nephron Research A.J. Rice – ...
Humana(HUM) - 2022 Q3 - Quarterly Report
2022-11-01 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...
Humana(HUM) - 2022 Q2 - Earnings Call Transcript
2022-07-27 18:37
Humana Inc. (NYSE:HUM) Q2 2022 Earnings Conference Call July 27, 2022 9:00 AM ET Company Participants Lisa Stoner - Vice President, Investor Relations Bruce Broussard - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Joe Ventura - Chief Legal Officer Conference Call Participants Justin Lake - Wolfe Research Matt Borsch - BMO Capital Markets Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Nathan Rich - Goldman Sachs Joshua Raskin - Nephron Research Ricky Goldwasser - ...
Humana(HUM) - 2022 Q2 - Quarterly Report
2022-07-26 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) Delaware 61-0647538 (State or other jurisdiction o ...
Humana(HUM) - 2022 Q1 - Earnings Call Transcript
2022-04-27 19:13
Humana Inc. (NYSE:HUM) Q1 2022 Earnings Conference Call April 27, 2022 9:00 AM ET Company Participants Lisa Stoner - Vice President, Investor Relations Bruce Broussard - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Joe Ventura - Chief Legal Officer Conference Call Participants Kevin Fischbeck - Bank of America Nathan Rich - Goldman Sachs Justin Lake - Wolfe Research Matthew Borsch - BMO Capital Markets Kevin Caliendo - UBS Kevin Caliendo - UBS A.J. Rice - Credit Suisse Steph ...
Humana(HUM) - 2022 Q1 - Quarterly Report
2022-04-26 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) Delaware 61-0647538 (State or other jurisdiction ...
Humana(HUM) - 2021 Q4 - Annual Report
2022-02-16 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation of organization) ...
Humana(HUM) - 2021 Q4 - Earnings Call Transcript
2022-02-02 17:14
Humana Inc. (NYSE:HUM) Q4 2021 Earnings Conference Call February 2, 2022 9:00 AM ET Company Participants Lisa Stoner – Vice President-Investor Relations Bruce Broussard – President and Chief Executive Officer Susan Diamond – Chief Financial Officer Joe Ventura – Chief Legal Officer Conference Call Participants Matthew Borsch – BMO Capital Markets Justin Lake – Wolfe Research Kevin Fischbeck – Bank of America Stephen Baxter – Wells Fargo A.J. Rice – Credit Suisse Josh Raskin – Nephron Research Scott Fidel – ...
Humana(HUM) - 2021 Q3 - Earnings Call Transcript
2021-11-03 19:29
Humana Inc. (NYSE:HUM) Q3 2021 Earnings Conference Call November 3, 2021 9:00 AM ET Company Participants Lisa Stoner – Vice President of Investor Relations Bruce Broussard – President and Chief Executive Officer Susan Diamond – Chief Financial Officer Conference Call Participants Kevin Fischbeck – Bank of America Matthew Borsch – BMO Capital Markets Stephen Baxter – Wells Fargo Ricky Goldwasser – Morgan Stanley Joshua Raskin – Nephron Research LLC Kevin Caliendo – UBS Scott Fidel – Stephens Ralph Giacobbe – ...
Humana(HUM) - 2021 Q3 - Quarterly Report
2021-11-02 16:00
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) Delaware 61-0647538 (State or other jurisdict ...